Wound Care - Turkey

  • Turkey
  • Revenue in the Wound Care market amounts to US$16.15m in 2024. The market is expected to grow annually by -0.72% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$1,052m in 2024).
  • In relation to total population figures, per person revenues of US$0.19 are generated in 2024.

Key regions: Philippines, India, Europe, United States, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care market in Turkey has been experiencing significant growth in recent years, driven by various factors such as increasing healthcare expenditure, a growing aging population, and rising awareness about the importance of wound care. Customer preferences in the Wound Care market in Turkey have been shifting towards advanced wound care products and technologies.

This is primarily due to the benefits offered by these products, such as faster healing, reduced risk of infection, and improved patient comfort. Additionally, there is a growing demand for products that are easy to use and require minimal maintenance. Trends in the market indicate a strong focus on innovation and technological advancements.

Companies in the Wound Care market in Turkey are investing heavily in research and development to introduce new and improved products. This includes the development of advanced wound dressings, wound closure devices, and wound healing devices. The aim is to provide healthcare professionals with more effective and efficient tools to treat and manage wounds.

Local special circumstances in Turkey, such as a high prevalence of chronic diseases like diabetes and cardiovascular diseases, contribute to the growth of the Wound Care market. These conditions often lead to the development of chronic wounds, which require specialized care and treatment. As a result, there is a growing demand for wound care products and services in the country.

Underlying macroeconomic factors, such as increasing healthcare expenditure and a growing aging population, play a significant role in the development of the Wound Care market in Turkey. The government's focus on improving healthcare infrastructure and increasing access to healthcare services has led to an increase in the demand for wound care products. Additionally, the aging population in Turkey is more prone to developing chronic wounds, further driving the market growth.

In conclusion, the Wound Care market in Turkey is witnessing significant growth due to factors such as increasing healthcare expenditure, a growing aging population, and rising awareness about the importance of wound care. Customer preferences are shifting towards advanced wound care products, and there is a strong focus on innovation and technological advancements. Local special circumstances, such as a high prevalence of chronic diseases, contribute to the growth of the market.

Underlying macroeconomic factors, such as increasing healthcare expenditure and a growing aging population, further drive the market development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)